The inflammatory and immune response to Helicobacter pylori infection

Best Practice and Research: Clinical Gastroenterology

Volumn 21, Issue 2, 2007, Pages 237-259

  Robinson, Karen ^a   Argent, Richard H ^a   Atherton, John C ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

acquired immunity; BabA; cag pathogenicity island; CagA; DupA; FoxP3; gastric adenocarcinoma; gastric cancer; Helicobacter pylori; immunisation; inflammation; innate immunity; Nod1; OipA; peptic ulceration; regulatory T cells; T helper; TLR; Toll like receptors; VacA; vaccines

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; CAGA PROTEIN; CATALASE; CHOLERA TOXIN; DNA VACCINE; HEAT SHOCK PROTEIN; HELICOBACTER PYLORI VACCINE; LIVE VACCINE; METRONIDAZOLE; RECOMBINANT VACCINE; RNA POLYMERASE BETA SUBUNIT; UREASE; VACUOLATING TOXIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CANCER RISK; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CLINICAL FEATURE; CLINICAL TRIAL; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; DRUG SYNTHESIS; GASTRITIS; GENETIC CODE; GENETIC RISK; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HELPER CELL; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOSTIMULATION; INNATE IMMUNITY; LOW DRUG DOSE; NONHUMAN; PATHOGENESIS; PATHOGENICITY ISLAND; PEPTIC ULCER; REGULATORY T LYMPHOCYTE; RISK ASSESSMENT; RISK FACTOR; STOMACH CANCER; STOMACH CARCINOGENESIS;

ACUTE DISEASE; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; CELL DIFFERENTIATION; CHRONIC DISEASE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNITY, NATURAL; INFLAMMATION; LEUKOCYTES; PHOSPHORYLATION; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 33947312885     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2007.01.001     Document Type: Article

References (199)

1. Blaser M.J., and Atherton J.C. Helicobacter pylori persistence: biology and disease. J Clin Invest 113 3 (Feb 2004) 321-333
2. Atherton J.C. The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annu Rev Pathol Mech Dis 1 (February 2006) 63-96
3. Marshall B.J., Armstrong J.A., McGechie D.B., et al. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust 142 8 (Apr 1985) 436-439
4. Morris A., and Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 82 3 (Mar 1987) 192-199
5. Sobala G.M., Crabtree J.E., Dixon M.F., et al. Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut 32 11 (Nov 1991) 1415-1418
6. Graham D.Y., Opekun A.R., Osato M.S., et al. Challenge model for Helicobacter pylori infection in human volunteers. Gut 53 9 (Sep 2004) 1235-1243
7. Harford W.V., Barnett C., Lee E., et al. Acute gastritis with hypochlorhydria: report of 35 cases with long term follow up. Gut 47 4 (Oct 2000) 467-472
8. Censini S., Lange C., Xiang Z., et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 93 25 (10 Dec 1996) 14648-14653
9. Figueiredo C., Machado J.C., Pharoah P., et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 94 22 (20 Nov 2002) 1680-1687
10. Crabtree J.E., Shallcross T.M., Heatley R.V., et al. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 32 12 (Dec 1991) 1473-1477
11. Nomura A.M., Perez-Perez G.I., Lee J., et al. Relation between Helicobacter pylori cagA status and risk of peptic ulcer disease. Am J Epidemiol 155 11 (Jun 2002) 1054-1059
12. Blaser M.J., Perez-Perez G.I., Kleanthous H., et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55 10 (15 May 1995) 2111-2115
13. Asahi M., Azuma T., Ito S., et al. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med 191 4 (21 Feb 2000) 593-602
14. Odenbreit S., Puls J., Sedlmaier B., et al. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287 5457 (25 Feb 2000) 1497-1500
15. Stein M., Rappuoli R., and Covacci A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci USA 97 3 (1 Feb 2000) 1263-1268
16. Crabtree J.E., Covacci A., Farmery S.M., et al. Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol 48 1 (Jan 1995) 41-45
17. Peek Jr. R.M., Miller G.G., Tham K.T., et al. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest 73 6 (Dec 1995) 760-770
18. Viala J., Chaput C., Boneca I.G., et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 5 11 (Nov 2004) 1166-1174
19. Girardin S.E., Boneca I.G., Carneiro L.A., et al. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300 5625 (6 Jun 2003) 1584-1587
20. Girardin S.E., Travassos L.H., Herve M., et al. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem 278 43 (24 Oct 2003) 41702-41708
21. Inohara N., and Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 3 5 (May 2003) 371-382
22. Selbach M., Moese S., Hauck C.R., et al. Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem 277 9 (1 Mar 2002) 6775-6778
23. Stein M., Bagnoli F., Halenbeck R., et al. c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol Microbiol 43 4 (Feb 2002) 971-980
24. Higashi H., Tsutsumi R., Muto S., et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295 5555 (25 Jan 2002) 683-686
25. Rieder G., Fischer W., and Haas R. Interaction of Helicobacter pylori with host cells: function of secreted and translocated molecules. Curr Opin Microbiol 8 1 (Feb 2005) 67-73
26. Suzuki M., Mimuro H., Suzuki T., et al. Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion. J Exp Med 202 9 (7 Nov 2005) 1235-1247
27. Mimuro H., Suzuki T., Tanaka J., et al. Grb2 is a key mediator of helicobacter pylori CagA protein activities. Mol Cell 10 4 (Oct 2002) 745-755
28. Amieva M.R., Vogelmann R., Covacci A., et al. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300 5624 (30 May 2003) 1430-1434
29. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 4 9 (Sep 2004) 688-694
30. Argent R.H., Kidd M., Owen R.J., et al. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 127 2 (Aug 2004) 514-523
31. Azuma T., Yamakawa A., Yamazaki S., et al. Correlation between variation of the 3′ region of the cagA gene in Helicobacter pylori and disease outcome in Japan. J Infect Dis 186 11 (1 Dec 2002) 1621-1630
32. Yamaoka Y., Kodama T., Kashima K., et al. Variants of the 3′ region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol 36 8 (Aug 1998) 2258-2263
33. Yamaoka Y., El-Zimaity H.M., Gutierrez O., et al. Relationship between the cagA 3′ repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology 117 2 (Aug 1999) 342-349
34. Tummuru M.K., Sharma S.A., and Blaser M.J. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol 18 5 (Dec 1995) 867-876
35. Crabtree J.E., Xiang Z., Lindley I.J., et al. Induction of interleukin-8 secretion from gastric epithelial cells by a cagA negative isogenic mutant of Helicobacter pylori. J Clin Pathol 48 10 (Oct 1995) 967-969
36. Sharma S.A., Tummuru M.K., Blaser M.J., et al. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol 160 5 (1 Mar 1998) 2401-2407
37. Fischer W., Puls J., Buhrdorf R., et al. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol Microbiol 42 5 (Dec 2001) 1337-1348
38. Brandt S., Kwok T., Hartig R., et al. NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci USA 102 26 (28 Jun 2005) 9300-9305
39. Kim S.Y., Lee Y.C., Kim H.K., et al. Helicobacter pylori CagA transfection of gastric epithelial cells induces interleukin-8. Cell Microbiol 8 1 (Jan 2006) 97-106
40. Ando T., Peek Jr. R.M., Lee Y.C., et al. Host cell responses to genotypically similar Helicobacter pylori isolates from United States and Japan. Clin Diagn Lab Immunol 9 1 (Jan 2002) 167-175
41. Backert S., Schwarz T., Miehlke S., et al. Functional analysis of the cag pathogenicity island in Helicobacter pylori isolates from patients with gastritis, peptic ulcer, and gastric cancer. Infect Immun 72 2 (Feb 2004) 1043-1056
42. Wirth H.P., Beins M.H., Yang M., et al. Experimental infection of Mongolian gerbils with wild-type and mutant Helicobacter pylori strains. Infect Immun 66 10 (Oct 1998) 4856-4866
43. Yamaoka Y., Kwon D.H., and Graham D.Y. A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci USA 97 13 (20 Jun 2000) 7533-7538
44. Yamaoka Y., Kikuchi S., el-Zimaity H.M., et al. Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology 123 2 (Aug 2002) 414-424
45. Yamaoka Y., Ojo O., Fujimoto S., et al. Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut 55 6 (Jun 2006) 775-781
46. Yamaoka Y., Kita M., Kodama T., et al. Helicobacter pylori infection in mice: Role of outer membrane proteins in colonization and inflammation. Gastroenterology 123 6 (Dec 2002) 1992-2004
47. Kudo T., Lu H., Wu J.Y., et al. Regulation of RANTES promoter activation in gastric epithelial cells infected with Helicobacter pylori. Infect Immun 73 11 (Nov 2005) 7602-7612
48. Lu H., Wu J.Y., Kudo T., et al. Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori. Mol Biol Cell 16 10 (Oct 2005) 4954-4966
49. Akanuma M., Maeda S., Ogura K., et al. The evaluation of putative virulence factors of Helicobacter pylori for gastroduodenal disease by use of a short-term Mongolian gerbil infection model. J Infect Dis 185 3 (1 Feb 2002) 341-347
50. de Jonge R., Pot R.G., Loffeld R.J., et al. The functional status of the Helicobacter pylori sabB adhesin gene as a putative marker for disease outcome. Helicobacter 9 2 (Apr 2004) 158-164
51. Lu H., Hsu P.I., Graham D.Y., et al. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 128 4 (Apr 2005) 833-848
52. Ilver D., Arnqvist A., Ogren J., et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279 5349 (16 Jan 1998) 373-377
53. Gerhard M., Lehn N., Neumayer N., et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci USA 96 22 (26 Oct 1999) 12778-12783
54. Rad R., Gerhard M., Lang R., et al. The Helicobacter pylori blood group antigen-binding adhesin facilitates bacterial colonization and augments a nonspecific immune response. J Immunol 168 6 (15 Mar 2002) 3033-3041
55. Lee K.H., Cho M.J., Yamaoka Y., et al. Alanine-threonine polymorphism of Helicobacter pylori RpoB is correlated with differential induction of interleukin-8 in MKN45 cells. J Clin Microbiol 42 8 (Aug 2004) 3518-3524
56. El-Omar E.M., Carrington M., Chow W.H., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 6776 (23 Mar 2000) 398-402
57. Machado J.C., Figueiredo C., Canedo P., et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 125 2 (Aug 2003) 364-371
58. El-Omar E.M., Rabkin C.S., Gammon M.D., et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124 5 (May 2003) 1193-1201
59. Rad R., Prinz C., Neu B., et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 188 2 (15 Jul 2003) 272-281
60. Jung H.C., Kim J.M., Song I.S., et al. Helicobacter pylori induces an array of pro-inflammatory cytokines in human gastric epithelial cells: quantification of mRNA for interleukin-8, -1 alpha/beta, granulocyte-macrophage colony-stimulating factor, monocyte chemoattractant protein-1 and tumour necrosis factor-alpha. J Gastroenterol Hepatol 12 7 (Jul 1997) 473-480
61. George J.T., Boughan P.K., Karageorgiou H., et al. Host anti-microbial response to Helicobacter pylori infection. Mol Immunol 40 7 (Nov 2003) 451-456
62. Gobert A.P., Bambou J.C., Werts C., et al. Helicobacter pylori heat shock protein 60 mediates interleukin-6 production by macrophages via a toll-like receptor (TLR)-2-, TLR-4-, and myeloid differentiation factor 88-independent mechanism. J Biol Chem 279 1 (2 Jan 2004) 245-250
63. Harris P.R., Ernst P.B., Kawabata S., et al. Recombinant Helicobacter pylori urease activates primary mucosal macrophages. J Infect Dis 178 5 (Nov 1998) 1516-1520
64. Zhang Q., Dawodu J.B., Etolhi G., et al. Relationship between the mucosal production of reactive oxygen radicals and density of Helicobacter pylori in patients with duodenal ulcer. Eur J Gastroenterol Hepatol 9 3 (Mar 1997) 261-265
65. Yamaoka Y., Kita M., Kodama T., et al. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 41 4 (Oct 1997) 442-451
66. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3 2 (Feb 2003) 133-146
67. Nurnberger T., Brunner F., Kemmerling B., et al. Innate immunity in plants and animals: striking similarities and obvious differences. Immunol Rev 198 (Apr 2004) 249-266
68. Netea M.G., van der Graaf C., Van der Meer J.W., et al. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system. J Leukoc Biol 75 5 (May 2004) 749-755
69. Torok A.M., Bouton A.H., and Goldberg J.B. Helicobacter pylori induces interleukin-8 secretion by Toll-like receptor 2- and Toll-like receptor 5-dependent and -independent pathways. Infect Immun 73 3 (Mar 2005) 1523-1531
70. Ding S.Z., Torok A.M., Smith Jr. M.F., et al. Toll-like receptor 2-mediated gene expression in epithelial cells during Helicobacter pylori infection. Helicobacter 10 3 (Jun 2005) 193-204
71. Gewirtz A.T., Yu Y., Krishna U.S., et al. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. J Infect Dis 189 10 (May 2004) 1914-1920
72. Ishihara S., Rumi M.A., Kadowaki Y., et al. Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis. J Immunol 173 2 (15 Jul 2004) 1406-1416
73. Smith Jr. M.F., Mitchell A., Li G., et al. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J Biol Chem 278 35 (29 Aug 2003) 32552-32560
74. Mandell L., Moran A.P., Cocchiarella A., et al. Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4. Infect Immun 72 11 (Nov 2004) 6446-6454
75. Chang Y.J., Wu M.S., Lin J.T., et al. Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-kappaB activation. Mol Pharmacol 66 6 (Dec 2004) 1465-1477
76. Schmausser B., Andrulis M., Endrich S., et al. Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol 136 3 (Jun 2004) 521-526
77. Lee S.K., Stack A., Katzowitsch E., et al. Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5. Microbes Infect 5 15 (Dec 2003) 1345-1356
78. Isomoto H., Mukae H., Ishimoto H., et al. Elevated concentrations of alpha-defensins in gastric juice of patients with Helicobacter pylori infection. Am J Gastroenterol 99 10 (Oct 2004) 1916-1923
79. Allaker R.P., and Kapas S. Adrenomedullin and mucosal defence: interaction between host and microorganism. Regul Pept 112 1-3 (15 Apr 2003) 147-152
80. Kitadai Y., Sasaki A., Ito M., et al. Helicobacter pylori infection influences expression of genes related to angiogenesis and invasion in human gastric carcinoma cells. Biochem Biophys Res Commun 311 4 (Nov 2003) 809-814
81. Hase K., Murakami M., Iimura M., et al. Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. Gastroenterology 125 6 (Dec 2003) 1613-1625
82. Boughan P.K., Argent R.H., Body-Malapel M., et al. Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: critical regulators of beta-defensins during Helicobacter pylori infection. J Biol Chem 281 17 (28 Apr 2006) 11637-11648
83. Ernst P.B., and Gold B.D. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol 54 (2000) 615-640
84. Kranzer K., Sollner L., Aigner M., et al. Impact of Helicobacter pylori virulence factors and compounds on activation and maturation of human dendritic cells. Infect Immun 73 7 (Jul 2005) 4180-4189
85. Hafsi N., Voland P., Schwendy S., et al. Human dendritic cells respond to Helicobacter pylori, promoting NK cell and Th1-effector responses in vitro. J Immunol 173 2 (15 Jul 2004) 1249-1257
86. Guiney D.G., Hasegawa P., and Cole S.P. Helicobacter pylori preferentially induces interleukin 12 (IL-12) rather than IL-6 or IL-10 in human dendritic cells. Infect Immun 71 7 (Jul 2003) 4163-4166
87. Meyer F., Wilson K.T., and James S.P. Modulation of innate cytokine responses by products of Helicobacter pylori. Infect Immun 68 11 (Nov 2000) 6265-6272
88. Odenbreit S., Linder S., Gebert-Vogl B., et al. Interleukin-6 induction by Helicobacter pylori in human macrophages is dependent on phagocytosis. Helicobacter 11 3 (Jun 2006) 196-207
89. Allen L.A., Schlesinger L.S., and Kang B. Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. J Exp Med 191 1 (3 Jan 2000) 115-128
90. Allen L.A. The role of the neutrophil and phagocytosis in infection caused by Helicobacter pylori. Curr Opin Infect Dis 14 3 (Jun 2001) 273-277
91. Schwartz J.T., and Allen L.A. Role of urease in megasome formation and Helicobacter pylori survival in macrophages. J Leukoc Biol 79 6 (Jun 2006) 1214-1225
92. Rittig M.G., Shaw B., Letley D.P., et al. Helicobacter pylori-induced homotypic phagosome fusion in human monocytes is independent of the bacterial vacA and cag status. Cell Microbiol 5 12 (Dec 2003) 887-899
93. Ramarao N., Gray-Owen S.D., and Meyer T.F. Helicobacter pylori induces but survives the extracellular release of oxygen radicals from professional phagocytes using its catalase activity. Mol Microbiol 38 1 (Oct 2000) 103-113
94. Bamba N., Nakajima S., Andoh A., et al. Stem cell factor expressed in human gastric mucosa in relation to mast cell increase in Helicobacter pylori-infected gastritis. Dig Dis Sci 47 2 (Feb 2002) 274-282
95. Yakabi K., Arimura T., Koyanagi M., et al. Effects of interleukin-8 and Helicobacter pylori on histamine release from isolated canine gastric mucosal mast cells. J Gastroenterol 37 1 (Jan 2002) 10-16
96. Nakajima S., Bamba N., and Hattori T. Histological aspects and role of mast cells in Helicobacter pylori-infected gastritis. Aliment Pharmacol Ther 20 Suppl. 1 (Jul 2004) 165-170
97. Velin D., Bachmann D., Bouzourene H., et al. Mast cells are critical mediators of vaccine-induced Helicobacter clearance in the mouse model. Gastroenterology 129 1 (Jul 2005) 142-155
98. Zevering Y., Jacob L., and Meyer T.F. Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development. Gut 45 3 (Sep 1999) 465-474
99. Chen W., Shu D., and Chadwick V.S. Helicobacter pylori infection: mechanism of colonization and functional dyspepsia Reduced colonization of gastric mucosa by Helicobacter pylori in mice deficient in interleukin-10. J Gastroenterol Hepatol 16 4 (Apr 2001) 377-383
100. Akhiani A.A., Pappo J., Kabok Z., et al. Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells. J Immunol 169 12 (Dec 2002) 6977-6984
101. Czinn S.J., Cai A., and Nedrud J.G. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 11 6 (1993) 637-642
102. Akhiani A.A., Schon K., Franzen L.E., et al. Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infection. J Immunol 172 8 (15 Apr 2004) 5024-5033
103. Akhiani A.A., Stensson A., Schon K., et al. IgA antibodies impair resistance against Helicobacter pylori infection: studies on immune evasion in IL-10-deficient mice. J Immunol 174 12 (15 Jun 2005) 8144-8153
104. Gonzalez-Valencia G., Perez-Perez G.I., Washburn R.G., et al. Susceptibility of Helicobacter pylori to the bactericidal activity of human serum. Helicobacter 1 1 (Mar 1996) 28-33
105. Ermak T.H., Giannasca P.J., Nichols R., et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med 188 12 (21 Dec 1998) 2277-2288
106. Sutton P., Wilson J., Kosaka T., et al. Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies. Immunol Cell Biol 78 1 (Feb 2000) 28-30
107. D'Elios M.M., Appelmelk B.J., Amedei A., et al. Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry. Trends Mol Med 10 7 (Jul 2004) 316-323
108. Appelmelk B.J., Simoons-Smit I., Negrini R., et al. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect Immun 64 6 (Jun 1996) 2031-2040
109. Amedei A., Bergman M.P., Appelmelk B.J., et al. Molecular mimicry between Helicobacter pylori antigens and H+, K+ -adenosine triphosphatase in human gastric autoimmunity. J Exp Med 198 8 (20 Oct 2003) 1147-1156
110. Bamford K.B., Fan X., Crowe S.E., et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 114 3 (Mar 1998) 482-492
111. D'Elios M.M., Manghetti M., De Carli M., et al. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 158 2 (15 Jan 1997) 962-967
112. Fan X.J., Chua A., Shahi C.N., et al. Gastric T lymphocyte responses to Helicobacter pylori in patients with H. pylori colonisation. Gut 35 10 (Oct 1994) 1379-1384
113. Ma J., Chen T., Mandelin J., et al. Regulation of macrophage activation. Cell Mol Life Sci 60 11 (Nov 2003) 2334-2346
114. Lehmann F.S., Terracciano L., Carena I., et al. In situ correlation of cytokine secretion and apoptosis in Helicobacter pylori-associated gastritis. Am J Physiol Gastrointest Liver Physiol 283 2 (Aug 2002) G481-G488
115. Gea C. IFN-gamma infusion induces gastric atrophy, metaplasia and dysplasia in the absence of Helicobacter pylori infection: a role for the immune response in Helicobacter disease. Gastroenterology 124 Suppl. 1 (2003) A19
116. Garhart C.A., Redline R.W., Nedrud J.G., et al. Clearance of Helicobacter pylori Infection and resolution of postimmunization gastritis in a kinetic study of prophylactically immunized mice. Infect Immun 70 7 (Jul 2002) 3529-3538
117. Smythies L.E., Waites K.B., Lindsey J.R., et al. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J Immunol 165 2 (15 Jul 2000) 1022-1029
118. Garhart C.A., Nedrud J.G., Heinzel F.P., et al. Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4. Infect Immun 71 6 (Jun 2003) 3628-3633
119. Eaton K.A., Mefford M., and Thevenot T. The role of T-cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J Immunol 166 12 (15 Jun 2001) 7456-7461
120. de Jonge R., Kuipers E.J., Langeveld S.C., et al. The Helicobacter pylori plasticity region locus jhp0947-jhp0949 is associated with duodenal ulcer disease and interleukin-12 production in monocyte cells. FEMS Immunol Med Microbiol 41 2 (1 Jun 2004) 161-167
121. Amedei A., Cappon A., Codolo G., et al. The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J Clin Invest 116 4 (Apr 2006) 1092-1101
122. Robinson K., Loughlin M., Potter R., and Jenks P. Host adaptation and immune modulation are mediated by homologous recombination in Helicobacter pylori. J Infect Dis 191 (2005) 579-587
123. Bergman M.P., Engering A., Smits H.H., et al. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J Exp Med 200 8 (Oct 2004) 979-990
124. Paziak-Domanska B., Chmiela M., Jarosinska A., et al. Potential role of CagA in the inhibition of T-cell reactivity in Helicobacter pylori infections. Cell Immunol 202 2 (15 Jun 2000) 136-139
125. Knipp U., Birkholz S., Kaup W., et al. Partial characterization of a cell proliferation-inhibiting protein produced by Helicobacter pylori. Infect Immun 64 9 (Sep 1996) 3491-3496
126. Gerhard M., Schmees C., Voland P., et al. A secreted low-molecular-weight protein from Helicobacter pylori induces cell-cycle arrest of T cells. Gastroenterology 128 5 (May 2005) 1327-1339
127. Molinari M., Salio M., Galli C., et al. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J Exp Med 187 1 (5 Jan 1998) 135-140
128. Gebert B., Fischer W., Weiss E., et al. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 301 5636 (22 Aug 2003) 1099-1102
129. Boncristiano M., Paccani S.R., Barone S., et al. The Helicobacter pylori vacuolating toxin inhibits T-cell activation by two independent mechanisms. J Exp Med 198 12 (15 Dec 2003) 1887-1897
130. Das S., Suarez G., Beswick E.J., et al. Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection. J Immunol 176 5 (1 Mar 2006) 3000-3009
131. Lunet N., and Barros H. Helicobacter pylori infection and gastric cancer: facing the enigmas. Int J Cancer 106 6 (10 Oct 2003) 953-960
132. Gressmann H., Linz B., Ghai R., et al. Gain and loss of multiple genes during the evolution of Helicobacter pylori. PLoS Genet 1 4 (Oct 2005) e43
133. Erdman S.E., Poutahidis T., Tomczak M., et al. CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol 162 2 (Feb 2003) 691-702
134. Satoguina J., Mempel M., Larbi J., et al. Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis). Microbes Infect 4 13 (Nov 2002) 1291-1300
135. Fox J.G., Beck P., Dangler C.A., et al. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat Med 6 5 (May 2000) 536-542
136. Li H., Stoicov C., Cai X., et al. Helicobacter and gastric cancer disease mechanisms: host response and disease susceptibility. Curr Gastroenterol Rep 5 6 (Dec 2003) 459-467
137. Mitchell H.M., Ally R., Wadee A., et al. Major differences in the IgG subclass response to Helicobacter pylori in the first and third worlds. Scand J Gastroenterol 37 5 (May 2002) 517-522
138. Itoh T., Wakatsuki Y., Yoshida M., et al. The vast majority of gastric T cells are polarized to produce T helper 1 type cytokines upon antigenic stimulation despite the absence of Helicobacter pylori infection. J Gastroenterol 34 5 (Oct 1999) 560-570
139. Coombes J.L., Robinson N.J., Maloy K.J., et al. Regulatory T cells and intestinal homeostasis. Immunol Rev 204 (Apr 2005) 184-194
140. Hawrylowicz C.M., and O'Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 5 4 (Apr 2005) 271-283
141. Piccirillo C.A., Tritt M., Sgouroudis E., et al. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice. Ann NY Acad Sci 1051 (Jun 2005) 72-87
142. Belkaid Y., Piccirillo C.A., Mendez S., et al. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420 6915 (5 Dec 2002) 502-507
143. McGuirk P., McCann C., and Mills K.H. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med 195 2 (21 Jan 2002) 221-231
144. Thompson C., and Powrie F. Regulatory T cells. Curr Opin Pharmacol 4 4 (Aug 2004) 408-414
145. O'Garra A., Vieira P.L., Vieira P., et al. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest 114 10 (Nov 2004) 1372-1378
146. Weiner H.L. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 182 (Aug 2001) 207-214
147. Mills K.H., and McGuirk P. Antigen-specific regulatory T cells-their induction and role in infection. Semin Immunol 16 2 (Apr 2004) 107-117
148. Ziegler S.F. FOXP3: of mice and men. Annu Rev Immunol 24 (2006) 209-226
149. Chatila T.A., Blaeser F., Ho N., et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 106 12 (Dec 2000) R75-R81
150. Khattri R., Cox T., Yasayko S.A., et al. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4 4 (Apr 2003) 337-342
151. Lundgren A., Stromberg E., Sjoling A., et al. Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients. Infect Immun 73 1 (Jan 2005) 523-531
152. Lindholm C., Quiding-Jarbrink M., Lonroth H., et al. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 66 12 (Dec 1998) 5964-5971
153. Hida N., Shimoyama Jr. T., Neville P., et al. Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration. J Clin Pathol 52 9 (Sep 1999) 658-664
154. Lundgren A., Suri-Payer E., Enarsson K., et al. Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun 71 4 (Apr 2003) 1755-1762
155. Stromberg E., Edebo A., Lundin B.S., et al. Down-regulation of epithelial IL-8 responses in Helicobacter pylori-infected duodenal ulcer patients depends on host factors, rather than bacterial factors. Clin Exp Immunol 140 1 (Apr 2005) 117-125
156. Matsumoto Y., Blanchard T.G., Drakes M.L., et al. Eradication of Helicobacter pylori and resolution of gastritis in the gastric mucosa of IL-10-deficient mice. Helicobacter 10 5 (Oct 2005) 407-415
157. Kaparakis M., Laurie K.L., Wijburg O., et al. CD4+ CD25+ regulatory T cells modulate the T-cell and antibody responses in helicobacter-infected BALB/c mice. Infect Immun 74 6 (Jun 2006) 3519-3529
158. Raghavan S., Fredriksson M., Svennerholm A.M., et al. Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice. Clin Exp Immunol 132 3 (Jun 2003) 393-400
159. Anderson K.M., Czinn S.J., Redline R.W., et al. Induction of CTLA-4-mediated anergy contributes to persistent colonization in the murine model of gastric Helicobacter pylori infection. J Immunol 176 9 (1 May 2006) 5306-5313
160. Raghavan S., Suri-Payer E., and Holmgren J. Antigen-specific in vitro suppression of murine Helicobacter pylori-reactive immunopathological T cells by CD4CD25 regulatory T cells. Scand J Immunol 60 1-2 (Jul-Aug 2004) 82-88
161. Shirai M., Arichi T., Nakazawa T., et al. Persistent infection by Helicobacter pylori down-modulates virus-specific CD8+ cytotoxic T-cell response and prolongs viral infection. J Infect Dis 177 1 (Jan 1998) 72-80
162. McCune A., Lane A., Murray L., et al. Reduced risk of atopic disorders in adults with Helicobacter pylori infection. Eur J Gastroenterol Hepatol 15 6 (Jun 2003) 637-640
163. Kosunen T.U., Hook-Nikanne J., Salomaa A., et al. Increase of allergen-specific immunoglobulin E antibodies from 1973 to 1994 in a Finnish population and a possible relationship to Helicobacter pylori infections. Clin Exp Allergy 32 3 (Mar 2002) 373-378
164. Rook G.A., and Brunet L.R. Microbes, immunoregulation, and the gut. Gut 54 3 (Mar 2005) 317-320
165. Kim J.M., Kim J.S., Kim N., et al. Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients. Int J Antimicrob Agents 28 1 (Jul 2006) 6-13
166. Lwai-Lume L., Ogutu E.O., Amayo E.O., et al. Drug susceptibility pattern of Helicobacter pylori in patients with dyspepsia at the Kenyatta National Hospital, Nairobi. East Afr Med J 82 12 (Dec 2005) 603-608
167. Sutton P., Wilson J., and Lee A. Further development of the Helicobacter pylori mouse vaccination model. Vaccine 18 24 (1 Jun 2000) 2677-2685
168. Kotloff K.L., Sztein M.B., Wasserman S.S., et al. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Infect Immun 69 6 (Jun 2001) 3581-3590
169. Radcliff F.J., and Ferrero R.L. Effect of low-dose antigen exposure on development of immunity to Helicobacter pylori infection in mice. Infect Immun 69 8 (Aug 2001) 5186-5188
170. Michetti P., Corthesy-Theulaz I., Davin C., et al. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology 107 4 (Oct 1994) 1002-1011
171. Solnick J.V., Canfield D.R., Hansen L.M., et al. Immunization with recombinant Helicobacter pylori urease in specific-pathogen-free rhesus monkeys (Macaca mulatta). Infect Immun 68 5 (May 2000) 2560-2565
172. Satin B., Del Giudice G., Della Bianca V., et al. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med 191 9 (1 May 2000) 1467-1476
173. Rossi G., Ruggiero P., Peppoloni S., et al. Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity, and efficacy. Infect Immun 72 6 (Jun 2004) 3252-3259
174. Marchetti M., Rossi M., Giannelli V., et al. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant. Vaccine 16 1 (Jan 1998) 33-37
175. Radcliff F.J., Hazell S.L., Kolesnikow T., et al. Catalase, a novel antigen for Helicobacter pylori vaccination. Infect Immun 65 11 (Nov 1997) 4668-4674
176. Kamiya S., Osaki T., Taguchi H., et al. Immune response to heat shock protein of Helicobacter pylori-a candidate as a vaccine component. Keio J Med 51 Suppl. 2 (Dec 2002) 24-25
177. Taylor J.M., Ziman M.E., Huff J.L., et al. Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice. Vaccine 24 23 (5 Jun 2006) 4987-4994
178. Bumann D., Aksu S., Wendland M., et al. Proteome analysis of secreted proteins of the gastric pathogen Helicobacter pylori. Infect Immun 70 7 (Jul 2002) 3396-3403
179. Dutta A., Singh S.K., Ghosh P., et al. In silico identification of potential therapeutic targets in the human pathogen Helicobacter pylori. In Silico Biol 6 1-2 (2006) 43-47
180. Radcliff F.J., Chen M., and Lee A. Protective immunization against Helicobacter stimulates long-term immunity. Vaccine 14 8 (Jun 1996) 780-784
181. Levine M.M., Black R.E., Clements M.L., et al. Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine. Infect Immun 43 2 (Feb 1984) 515-522
182. Yang X.L., Liu W.C., Yang W.W., et al. Oral immunization of mice with vaccine of attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit. Biomed Environ Sci 18 6 (Dec 2005) 411-418
183. Corthesy B., Boris S., Isler P., et al. Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis. J Infect Dis 192 8 (Oct 2005) 1441-1449
184. Smythies L.E., Novak M.J., Waites K.B., et al. Poliovirus replicons encoding the B subunit of Helicobacter pylori urease protect mice against H. pylori infection. Vaccine 23 7 (4 Jan 2005) 901-909
185. Gu Q., Han N., Liu J., et al. Expression of Helicobacter pylori urease subunit B gene in transgenic rice. Biotechnol Lett 28 20 (Oct 2006) 1661-1666
186. Gu Q., Han N., Liu J., et al. Cloning of Helicobacter pylori urease subunit B gene and its expression in tobacco (Nicotiana tabacum L.). Plant Cell Rep 24 9 (Nov 2005) 532-539
187. Hatzifoti C., Roussel Y., Harris A.G., et al. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori. Helicobacter 11 2 (Apr 2006) 113-122
188. Akhiani A.A., Stensson A., Schon K., et al. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization. Scand J Immunol 63 2 (Feb 2006) 97-105
189. Lindkvist P., Asrat D., Nilsson I., et al. Age at acquisition of Helicobacter pylori infection: comparison of a high and a low prevalence country. Scand J Infect Dis 28 2 (1996) 181-184
190. Fadel S., and Sarzotti M. Cellular immune responses in neonates. Int Rev Immunol 19 2-3 (2000) 173-193
191. Clancy R., Borody T., Ren Z., et al. Can the response to eradication therapy in Helicobacter pylori infection be predicted?. Can J Gastroenterol 17 Suppl B (Jun 2003) 58B-61B
192. Ghiara P., Rossi M., Marchetti M., et al. Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection. Infect Immun 65 12 (Dec 1997) 4996-5002
193. Nystrom J., Raghavan S., and Svennerholm A.M. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice. Microbes Infect 8 2 (Feb 2006) 442-449
194. Ikewaki J., Nishizono A., Goto T., et al. Therapeutic oral vaccination induces mucosal immune response sufficient to eliminate long-term Helicobacter pylori infection. Microbiol Immunol 44 1 (2000) 29-39
195. Sutton P., Danon S.J., Walker M., et al. Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study. Gut 49 4 (Oct 2001) 467-473
196. Kleanthous H., Tibbitts T.J., Gray H.L., et al. Sterilizing immunity against experimental Helicobacter pylori infection is challenge-strain dependent. Vaccine 19 32 (14 Sep 2001) 4883-4895
197. Krakowka S., Eaton K.A., Rings D.M., et al. Gastritis induced by Helicobacter pylori in gnotobiotic piglets. Rev Infect Dis 13 Suppl. 8 (Jul-Aug 1991) S681-S685
198. Jeremy A.H., Du Y., Dixon M.F., et al. Protection against Helicobacter pylori infection in the Mongolian gerbil after prophylactic vaccination. Microbes Infect 8 2 (Feb 2006) 340-346
199. Michetti P., Kreiss C., Kotloff K.L., et al. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology 116 4 (Apr 1999) 804-812